CD36 and metabolic dysfunction-associated steatotic liver disease: Our previous study showed that overexpression of CD36 facilitates fatty acid uptake and impairs fatty acid oxidation, thus leading to the progression of nonalcoholic fatty liver disease (NAFLD)15.